Literature DB >> 27989373

Bleeding after invasive procedures is rare and unpredicted by platelet counts in cirrhotic patients with thrombocytopenia.

Grazia Napolitano1, Angelo Iacobellis2, Antonio Merla1, Grazia Niro1, Maria Rosa Valvano1, Fulvia Terracciano1, Domenico Siena1, Mariangela Caruso1, Antonio Ippolito1, Pier Mannucci Mannuccio3, Angelo Andriulli1.   

Abstract

BACKGROUND: In cirrhotics with low circulating platelets (PLT), restoration of normal cell counts has been traditionally recommended before invasive procedures. However, there is neither consensus on the PLT transfusion threshold nor evidence of its clinical efficacy. PATIENTS: In order to fill this gap of knowledge, we prospectively collected and analyzed data on circulating PLT counts [and International Normalized Ratio (INR)] values in a case series of 363 cirrhotics scheduled to undergo invasive investigations. PLT and/or fresh-frozen plasma (FFP) units were infused at the discretion of the attending physician, and the occurrence of post-procedural bleeding was related to pre-and post-infusion results.
RESULTS: 852 Procedures were carried out in 363 cirrhotics sub-grouped according to the Child-Pugh-Turcotte (CPT) classification (class A/B/C: 124/154/85). The infusion of PLT and/or FFP improved only marginally circulating PLT counts and INR values. Ten post-procedural bleeds occurred in the whole case series, i.e. 1 episode every 85 procedures or every 36 patients. Post-procedural bleeding was unrelated to the PLT counts, to the degree of INR abnormalities, nor to the CPT classes, but was more frequent in patients who underwent repeated investigations. In the 10 patients with the most profound alterations in PLT and/or INR values, no post-procedural bleeding occurred.
CONCLUSIONS: In cirrhotic patients with low PLT and/or abnormal INR values undergoing invasive investigations, post-procedural bleeding was rare and unpredicted by PLT counts or abnormal INR values. In particular, the recommendation to infuse platelets when counts are <50×103/L is not substantiated by this case series of cirrhotic patients.
Copyright © 2016. Published by Elsevier B.V.

Entities:  

Keywords:  Bleeding; Cirrhosis; Coagulation; Hemorrhage; Liver cirrhosis; Platelets

Mesh:

Year:  2016        PMID: 27989373     DOI: 10.1016/j.ejim.2016.11.007

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN: 0953-6205            Impact factor:   4.487


  29 in total

Review 1.  Bleeding Risk with Invasive Procedures in Patients with Cirrhosis and Coagulopathy.

Authors:  Nekisa Zakeri; Emmanuel A Tsochatzis
Journal:  Curr Gastroenterol Rep       Date:  2017-09

2.  Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study.

Authors:  S Basili; V Raparelli; L Napoleone; G Talerico; G R Corazza; F Perticone; D Sacerdoti; A Andriulli; A Licata; A Pietrangelo; A Picardi; G Raimondo; F Violi
Journal:  Am J Gastroenterol       Date:  2017-12-19       Impact factor: 10.864

3.  Thrombocytopenia in Chronic Liver Disease and the Role of Thrombopoietin Agonists.

Authors:  Jennifer B Miller; Esteban J Figueroa; Rebecca M Haug; Neeral L Shah
Journal:  Gastroenterol Hepatol (N Y)       Date:  2019-06

4.  Rebalanced hemostasis in liver disease: a misunderstood coagulopathy.

Authors:  Lara N Roberts
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

5.  Blood products and liver transplantation: A strategy to balance optimal preparation with effective blood stewardship.

Authors:  Christopher J Little; Glen E Leverson; Laura L Hammel; Joseph P Connor; David P Al-Adra
Journal:  Transfusion       Date:  2022-08-20       Impact factor: 3.337

Review 6.  Perioperative Evaluation and Management of Patients With Cirrhosis: Risk Assessment, Surgical Outcomes, and Future Directions.

Authors:  Kira L Newman; Kay M Johnson; Paul B Cornia; Peter Wu; Kamal Itani; George N Ioannou
Journal:  Clin Gastroenterol Hepatol       Date:  2019-07-31       Impact factor: 11.382

Review 7.  Platelets as Modulators of Liver Diseases.

Authors:  Ton Lisman; James P Luyendyk
Journal:  Semin Thromb Hemost       Date:  2017-09-12       Impact factor: 4.180

8.  Clinical Cirrhosis Dilemmas: Survey of Practice from the 7th International Coagulation in Liver Disease Conference.

Authors:  Jonathan G Stine; Nicolas M Intagliata; Neeral L Shah; Ton Lisman; Francesco Violi; Stephen H Caldwell; Curtis K Argo
Journal:  Dig Dis Sci       Date:  2019-10-18       Impact factor: 3.199

Review 9.  [Clinical presentation of bleeding in critically ill patients in the intensive care unit : Organ systems and clinical implications].

Authors:  Andreas Drolz; Valentin Fuhrmann
Journal:  Med Klin Intensivmed Notfmed       Date:  2021-08-24       Impact factor: 0.840

Review 10.  Procedure-related bleeding risk in patients with cirrhosis and severe thrombocytopenia.

Authors:  Domenico Alvaro; Nicola Caporaso; Edoardo Giovanni Giannini; Angelo Iacobellis; Mariacristina Morelli; Pierluigi Toniutto; Francesco Violi
Journal:  Eur J Clin Invest       Date:  2021-02-26       Impact factor: 4.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.